This message was sent to ##Email##
|
|
|
|
|
| |
AST
The American Society of Transplantation and its Transplantation & Immunology Research Network are pleased to highlight new clinical trials in transplantation that are currently enrolling or will be in the near future. This service is a benefit of participation in AST’s Corporate Affiliates Program. Click here for an overview and more information on these clinical trials.
AST
The AST Transplantation and Immunology Research Network (TIRN) research grants program funds innovative research in basic, clinical, and translational science. A limited number of grants will be awarded for research projects beginning July 1, 2017. The request for proposals is open now at www.TIRN.org/funding.
 |
|
• Write quality plans
• Document F-QAPI activities
• Review adverse events
• Assign tasks and to-do's
• Create meeting agendas and minutes
• Automate QA scorecards and reporting
• Analyze outcomes
|
|
AST
The nomination submission website for the 2017 AST Board of Directors is now open and accepting applications. AST recognizes the importance of electing strong leaders and encourages nominations from qualified AST members. Detailed information and the nomination criteria can be found here.
AST
The American Society of Transplantation (AST) is pleased to announce its call for nominations for 2017 Achievement Awards. Each year, the AST sponsors a variety of Achievement Awards in recognition of its members’ accomplishments and contributions to the field of transplantation. All nominations must be submitted by Friday, November 18, 2016. To view award categories and eligibility criteria, and to start your nomination, visit this link.
AST
Continue to pay it forward and recommend colleagues for membership for 2017. Any member who joins will receive the remainder of 2016 FREE and be paid through 2017. Visit www.myAST.org/payitforward for program details.
- Grand prize – Apple iPad and complimentary membership dues for 2018
- 2nd prize - $500 AST Bucks
- 3rd prize - $250 AST Bucks
To view all 2015-2016 Pay It Forward participants, click here.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Oct. 26, 2016 1 p.m. Online Activity
For more information: https://www.myast.org/education/webinars/optimizing-your-living-kidney-donor-program-1
AST
The AST continues to remain focused on transplant-related proposals coming out of CMS. Leadership from the Transplant Administrators COP was actively engaged in reviewing the July 14, 2016 public comment proposal and providing feedback to AST leadership. The AST's response may be reviewed here.
AST
AST's government relation team continues to actively monitor the ESRD Integrated Care Act (H.R. 5506 and S. 3090) due to its negative impact on kidney transplant recipients as currently drafted. A letter was submitted to sponsors of this bill in late July due to the AST's strong reservations regarding a capitated payment system that would create financial disincentive for referral of Medicare patients for transplant evaluation. Last week, the full House of Representatives Ways & Means Committee began its mark-up of the dialysis community driven ESRD capitated payment model demonstration legislation or "PATIENT Act." We will continue to monitor this important situation and keep members apprised of activity around this bill.
OPTN
There are 15 proposals currently out for public comment. Please take some time to review these proposals and share this information within your institutions. Feedback is critical to the policy development process. The AST's COPs are finalizing their review of proposals this week. Their responses will then go to the AST's Policy Committee for consideration to draft a unified AST response that will then go to the Board of Directors for approval before submission by the Oct. 14 deadline.
FDA
On Sept. 27, 2016, the FDA is conducting a public meeting on Patients Who Have Received an Organ Transplant. FDA is interested in obtaining patient input on the impact of receiving an organ transplant on daily life and patients’ views on currently available therapies to manage organ transplantation. To register to attend the meeting, either in person or via web, please visit this link.
Register today!
BeST16 Basic Science in Transplantation
The basic science community within our field is a tight-knit, dynamic group that benefits greatly from dedicated meeting opportunities to share knowledge and establish collaborations. As such, we hope you will join us at BeST16: Basic Science in Transplantation, a meeting jointly sponsored by the AST and ESOT.
HOUSING IS NOW OPEN
ATC
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science. The deadline to submit abstracts is Friday, Dec. 2, 2016. For more information regarding abstract submission, please click here.
Clinical Transplantation
Previous studies have reported contradictory results regarding the effect of pre-transplant dialysis modality on the outcomes after kidney transplantation (KT). To minimize the confounding effect of donor-related variables, we performed a donor-matched retrospective comparison of 160 patients that received only one modality of pre-transplant dialysis (peritoneal dialysis [PD] and hemodialysis [HD] in 80 patients each) and that subsequently underwent KT at our center between January 1990 and December 2007.
READ MORE
The Lancet
Chronic injury in kidney transplants remains a major cause of allograft loss. The aim of this study was to identify a gene set capable of predicting renal allografts at risk of progressive injury due to fibrosis.
READ MORE
Human Immunology
The “holy grail” of transplantation is donor specific tolerance in the absence of immunosuppression. There are no cases reported of survival without immunosuppression in heart transplant recipients. This prospective study identifies a group of heart transplant recipients who have developed tolerance to the transplanted organ. We hypothesize that these recipients were pre-disposed to survival without immunosuppression. Identification of a gene signature in these recipients could help understand the mechanism of development of transplant tolerance in heart transplant recipients.
READ MORE
American Journal of Transplantation
Acute kidney injury (AKI) and chronic kidney disease (CKD) are common in patients awaiting liver transplantation, and both have a marked impact on the perioperative and long-term morbidity and mortality of liver transplant recipients. Consequently, we reviewed the epidemiology of AKI and CKD in patients with end-stage liver disease, highlighted strategies to prevent and manage AKI, evaluated the changing liver transplant waiting list's impact on kidney function, delineated important considerations in simultaneous liver–kidney transplant selection, and projected possible future transplant policy changes and outcomes.
READ MORE
American Journal of Transplantation
Both acute and chronic kidney disease are common after liver transplantation and result in significant morbidity and mortality. The introduction of the Model for End-stage Liver Disease score has directly correlated with an increased prevalence of perioperative renal dysfunction and the number of simultaneous liver–kidney transplantations performed. Kidney dysfunction in this population is typically multifactorial and related to preexisting conditions, pretransplantation renal injury, perioperative events, and posttransplantation nephrotoxic immunosuppressive therapies.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
